Perinatal risk factors associated with acute kidney injury severity and duration among infants born extremely preterm.


Journal

Pediatric research
ISSN: 1530-0447
Titre abrégé: Pediatr Res
Pays: United States
ID NLM: 0100714

Informations de publication

Date de publication:
04 Mar 2024
Historique:
received: 07 11 2023
accepted: 03 02 2024
revised: 29 01 2024
pubmed: 5 3 2024
medline: 5 3 2024
entrez: 4 3 2024
Statut: aheadofprint

Résumé

We evaluated time-varying perinatal risk factors associated with early (≤7 post-natal days) and late (>7 post-natal days) severe acute kidney injury (AKI) occurrence and duration. A secondary analysis of Preterm Erythropoietin Neuroprotection Trial data. We defined severe AKI (stage 2 or 3) per neonatal modified Kidney Disease: Improving Global Outcomes criteria. Adjusted Cox proportional hazards models were conducted with exposures occurring at least 72 h before severe AKI. Adjusted negative binomial regression models were completed to evaluate risk factors for severe AKI duration. Of 923 participants, 2% had early severe AKI. In the adjusted model, gestational diabetes (adjusted HR (aHR) 5.4, 95% CI 1.1-25.8), non-steroidal anti-inflammatory drugs (NSAIDs) (aHR 3.2, 95% CI 1.0-9.8), and vancomycin (aHR 13.9, 95% CI 2.3-45.1) were associated with early severe AKI. Late severe AKI occurred in 22% of participants. Early severe AKI (aHR 2.5, 95% CI 1.1-5.4), sepsis (aHR 2.5, 95% CI 1.4-4.4), vasopressors (aHR 2.9, 95% CI 1.8-4.6), and diuretics (aHR 2.6, 95% CI 1.9-3.6) were associated with late severe AKI. Participants who had necrotizing enterocolitis or received NSAIDs had longer severe AKI duration. We identified major risk factors for severe AKI that can be the focus of future research. Time-dependent risk factors for severe acute kidney injury (AKI) and its duration are not well defined among infants born <28 weeks' gestation. Over 1 in 5 infants born <28 weeks' gestation experienced severe AKI, and this study identified several major time-dependent perinatal risk factors occurring within 72 h prior to severe AKI. This study can support efforts to develop risk stratification and clinical decision support to help mitigate modifiable risk factors to reduce severe AKI occurrence and duration.

Sections du résumé

BACKGROUND BACKGROUND
We evaluated time-varying perinatal risk factors associated with early (≤7 post-natal days) and late (>7 post-natal days) severe acute kidney injury (AKI) occurrence and duration.
METHODS METHODS
A secondary analysis of Preterm Erythropoietin Neuroprotection Trial data. We defined severe AKI (stage 2 or 3) per neonatal modified Kidney Disease: Improving Global Outcomes criteria. Adjusted Cox proportional hazards models were conducted with exposures occurring at least 72 h before severe AKI. Adjusted negative binomial regression models were completed to evaluate risk factors for severe AKI duration.
RESULTS RESULTS
Of 923 participants, 2% had early severe AKI. In the adjusted model, gestational diabetes (adjusted HR (aHR) 5.4, 95% CI 1.1-25.8), non-steroidal anti-inflammatory drugs (NSAIDs) (aHR 3.2, 95% CI 1.0-9.8), and vancomycin (aHR 13.9, 95% CI 2.3-45.1) were associated with early severe AKI. Late severe AKI occurred in 22% of participants. Early severe AKI (aHR 2.5, 95% CI 1.1-5.4), sepsis (aHR 2.5, 95% CI 1.4-4.4), vasopressors (aHR 2.9, 95% CI 1.8-4.6), and diuretics (aHR 2.6, 95% CI 1.9-3.6) were associated with late severe AKI. Participants who had necrotizing enterocolitis or received NSAIDs had longer severe AKI duration.
CONCLUSION CONCLUSIONS
We identified major risk factors for severe AKI that can be the focus of future research.
IMPACT STATEMENT UNASSIGNED
Time-dependent risk factors for severe acute kidney injury (AKI) and its duration are not well defined among infants born <28 weeks' gestation. Over 1 in 5 infants born <28 weeks' gestation experienced severe AKI, and this study identified several major time-dependent perinatal risk factors occurring within 72 h prior to severe AKI. This study can support efforts to develop risk stratification and clinical decision support to help mitigate modifiable risk factors to reduce severe AKI occurrence and duration.

Identifiants

pubmed: 38438550
doi: 10.1038/s41390-024-03102-w
pii: 10.1038/s41390-024-03102-w
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIDDK NIH HHS
ID : K23 DK131289
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL164434
Pays : United States
Organisme : NIDDK NIH HHS
ID : L40 DK130155
Pays : United States
Organisme : NHLBI NIH HHS
ID : K23 HL148394
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL146818
Pays : United States
Organisme : NHLBI NIH HHS
ID : L40 HL148910
Pays : United States

Investigateurs

Mamta Fuloria (M)
Mina Hanna (M)
Matthew W Harer (MW)
Cara Slagle (C)
Meredith P Schuh (MP)
Robert Woroniecki (R)

Informations de copyright

© 2024. The Author(s), under exclusive licence to the International Pediatric Research Foundation, Inc.

Références

Askenazi, D. J. et al. Prevalence of acute kidney injury (AKI) in extremely low gestational age neonates (ELGAN). Pediatr. Nephrol. (Berl., Ger.). 35, 1737–1748 (2020).
doi: 10.1007/s00467-020-04563-x
Aziz, K. B., Schles, E. M., Makker, K. & Wynn, J. L. Frequency of acute kidney injury and association with mortality among extremely preterm infants. JAMA Netw. Open. 5, e2246327 (2022). National Institutes of Health during the study but outside the submitted work. No other disclosures were reported.
doi: 10.1001/jamanetworkopen.2022.46327 pmcid: 9856227 pubmed: 36512358
Charlton, J. R. et al. Incidence and risk factors of early onset neonatal AKI. Clin. J. Am. Soc. Nephrol. : Cjasn. 14, 184–195 (2019).
doi: 10.2215/CJN.03670318 pmcid: 6390916 pubmed: 31738181
Charlton, J. R. et al. Late onset neonatal acute kidney injury: results from the AWAKEN Study. Pediatr. Res. 85, 339–348 (2019).
doi: 10.1038/s41390-018-0255-x pubmed: 30546043
Hingorani, S. et al. Prevalence and risk factors for kidney disease and elevated BP in 2-year-old children born extremely premature. Clin. J. Am. Soc. Nephrology. 17, 1129–1138 (2022).
doi: 10.2215/CJN.15011121
Selewski, D. T. et al. Neonatal acute kidney injury. Pediatrics 136, e463–e473 (2015).
doi: 10.1542/peds.2014-3819 pubmed: 26169430
Bruel, A. et al. Renal outcome in children born preterm with neonatal acute renal failure: IRENEO-a prospective controlled study. Pediatr. Nephrol. (Berl., Ger.). 31, 2365–2373 (2016).
doi: 10.1007/s00467-016-3444-z
Abitbol, C. L. et al. Long-term follow-up of extremely low birth weight infants with neonatal renal failure. Pediatr. Nephrol. (Berl., Ger.). 18, 887–893 (2003).
doi: 10.1007/s00467-003-1186-1
Harer, M. W., Pope, C. F., Conaway, M. R. & Charlton, J. R. Follow-up of acute kidney injury in neonates during childhood years (FANCY): a prospective cohort study. Pediatr. Nephrol. (Berl., Ger.). 32, 1067–1076 (2017).
doi: 10.1007/s00467-017-3603-x
Daga, A., Dapaah-Siakwan, F., Rajbhandari, S., Arevalo, C. & Salvador, A. Diagnosis and risk factors of acute kidney injury in very low birth weight infants. Pediatrics Neonatol. 58, 258–263 (2017).
doi: 10.1016/j.pedneo.2016.08.002
Sethi, S. K. et al. Risk factors and outcomes of neonates with acute kidney injury needing peritoneal dialysis: Results from the prospective TINKER (The Indian PCRRT-ICONIC Neonatal Kidney Educational Registry) study. Perit. Dialysis Int. 42, 460–469 (2022).
doi: 10.1177/08968608221091023
Uemura, O. et al. Perinatal factors contributing to chronic kidney disease in a cohort of Japanese children with very low birth weight. Pediatr. Nephrol. (Berl., Ger.). 36, 953–960 (2021).
doi: 10.1007/s00467-020-04791-1
Hidalgo, G. et al. Association of income level with kidney disease severity and progression among children and adolescents with CKD: a report from the Chronic Kidney Disease in Children (CKiD) Study. Am. J. Kidney Dis. 62, 1087–1094 (2013).
doi: 10.1053/j.ajkd.2013.06.013 pubmed: 23932090
Rhone, E. T., Carmody, J. B., Swanson, J. R. & Charlton, J. R. Nephrotoxic medication exposure in very low birth weight infants. J. Matern.-fetal Neonatal Med. 27, 1485–1490 (2014).
doi: 10.3109/14767058.2013.860522 pubmed: 24168068
Khor, C.-S. & Wang, W.-J. The role of acute kidney injury duration in clinical practice. Annals Transl. Med. 7, S88 1–3 (2019).
Han, S. S. et al. Duration of acute kidney injury and mortality in critically ill patients: a retrospective observational study. BMC Nephrol. 14, 1–7 (2013).
doi: 10.1186/1471-2369-14-133 pmcid: 3545884 pubmed: 23295127
Brown, J. R., Kramer, R. S., Coca, S. G. & Parikh, C. R. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann. Thorac. Surg. 90, 1142–1148 (2010).
doi: 10.1016/j.athoracsur.2010.04.039 pubmed: 20868804
Moffett, B. S. & Arikan, A. A. Trajectory of AKI in hospitalized pediatric patients-impact of duration and repeat events. Nephrol. Dialysis Transpl. 37, 1443–1450 (2022). Epub 2021/07/11. PubMed PMID: 34245299.
doi: 10.1093/ndt/gfab219
Juul, S. E. et al. A randomized trial of erythropoietin for neuroprotection in preterm infants. N. Engl. J. Med. 382, 233–243 (2020).
doi: 10.1056/NEJMoa1907423 pmcid: 7060076 pubmed: 31940698
Juul, S. E., Mayock, D. E., Comstock, B. A. & Heagerty, P. J. Neuroprotective potential of erythropoietin in neonates; design of a randomized trial. Matern. Health Neonatol. Perinatol. 1, 1–9 (2015).
doi: 10.1186/s40748-015-0028-z
Lazarus, B., Davies, M. R. P., Trubiano, J. A. & Pellicano, R. Time to acute kidney injury in β-lactam-induced acute interstitial nephritis. Kidney Int. Rep. 5, 1068–1070 (2020).
doi: 10.1016/j.ekir.2020.04.008 pmcid: 7335949 pubmed: 32647765
Jetton, J. G. et al. Incidence and outcomes of neonatal acute kidney injury (AWAKEN): a multicentre, multinational, observational cohort study. Lancet Child Adolesc. Health 1, 184–194 (2017).
doi: 10.1016/S2352-4642(17)30069-X pmcid: 5933049 pubmed: 29732396
Kaddourah, A., Basu, R. K., Bagshaw, S. M. & Goldstein, S. L. Epidemiology of acute kidney injury in critically Ill children and young adults. N. Engl. J. Med. 376, 11–20 (2017).
doi: 10.1056/NEJMoa1611391 pubmed: 27959707
Salerno, S. N. et al. Association between nephrotoxic drug combinations and acute kidney injury in the neonatal intensive care unit. J. Pediatr. 228, 213–219 (2021).
doi: 10.1016/j.jpeds.2020.08.035 pubmed: 32818481
Mohamed, T. H., Klamer B., Mahan J. D., Spencer J. D., & Slaughter, J. L. Diuretic therapy and acute kidney injury in preterm neonates and infants. Pediatric nephrology (Berlin, Germany). 2021. https://doi.org/10.1007/s00467-021-05132-6 .
Cerqueira, D. M. et al. In utero exposure to maternal diabetes impairs nephron progenitor differentiation. Am. J. Physiol. Ren. Physiol. 317, F1318–f30 (2019).
doi: 10.1152/ajprenal.00204.2019
Aliou, Y. et al. Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes. Pediatr. Res. 79, 416–424 (2016).
doi: 10.1038/pr.2015.236 pubmed: 26571223
Callaway, D. A. et al. Prematurity disrupts glomeruli development, whereas prematurity and hyperglycemia lead to altered nephron maturation and increased oxidative stress in newborn baboons. Pediatr. Res. 83, 702–711 (2018).
doi: 10.1038/pr.2017.290 pmcid: 5902650 pubmed: 29166383
Dyck, R. F. et al. Congenital anomalies of the kidney and urinary tract (CAKUT): An emerging relationship with pregestational diabetes mellitus among first nations and non-first nations people in Saskatchewan-results from the DIP: ORRIIGENSS project. Can. J. Diabetes 45, 346–54.e1 (2021).
doi: 10.1016/j.jcjd.2020.10.004 pubmed: 33308984
Venkatesh, K. K. et al. Risk of adverse pregnancy outcomes among pregnant individuals with gestational diabetes by race and ethnicity in the United States, 2014–2020. JAMA 327, 1356–1367 (2022) The National Institutes of Health outside the submitted work. No other disclosures were reported.
doi: 10.1001/jama.2022.3189 pmcid: 9006108 pubmed: 35412565
Smythe, C. M., Nickel, J. F. & Bradley, S. E. The effect of epinephrine (USP), l-epinephrine, and l-norepinephrine on glomerular filtration rate, renal plasma flow, and the urinary excretion of sodium, potassium, and water in normal man. J. Clin. Invest. 31, 499–506 (1952).
doi: 10.1172/JCI102634 pmcid: 436444 pubmed: 14927740
Hoogenberg, K., Smit, A. J. & Girbes, A. R. J. Effects of low-dose dopamine on renal and systemic hemodynamics during incremental norepinephrine infusion in healthy volunteers. Crit. Care Med. 26, 260–265 (1998).
doi: 10.1097/00003246-199802000-00022 pubmed: 9468162
Blatt, N. B., Srinivasan, S., Mottes, T., Shanley, M. M. & Shanley, T. P. Biology of sepsis: Its relevance to pediatric nephrology. Pediatr. Nephrol. (Berl., Ger.). 29, 2273–2287 (2014).
doi: 10.1007/s00467-013-2677-3
Sakr, Y., Dubois, M. J., De Backer, D., Creteur, J. & Vincent, J. L. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit. Care Med. 32, 1825–1831 (2004).
doi: 10.1097/01.CCM.0000138558.16257.3F pubmed: 15343008
Venkatachalam, M. A. & Weinberg, J. M. The tubule pathology of septic acute kidney injury: A neglected area of research comes of age. Kidney Int. 81, 338–340 (2012).
doi: 10.1038/ki.2011.401 pmcid: 3395426 pubmed: 22289794
Adegboyega, O. O., Singh, Y., Bhutada, A., Kupferman, J. C. & Rastogi, S. Recurrent acute kidney injury in preterm neonates is common and associated with worse outcomes and higher mortality. Pediatr. Res. 92, 284–290 (2022).
doi: 10.1038/s41390-021-01740-y pubmed: 34593979
Daraskevicius, J. et al. Phenotypes and baseline risk factors of acute kidney injury in children after allogeneic hematopoietic stem cell transplantation. Front Pediatr. 8, 499 (2020).
doi: 10.3389/fped.2020.00499 pmcid: 7481355 pubmed: 32984211
Siew, E. D. et al. Predictors of recurrent AKI. J. Am. Soc. Nephrology 27, 1190–1200 (2016).
doi: 10.1681/ASN.2014121218
DeFreitas M. J. et al. Maternal hypertension disorders and neonatal acute kidney injury: Results from the AWAKEN Study. Am. J. Perinatol. 2022. https://doi.org/10.1055/a-1780-2249 .
Garg P. M. et al. Severe acute kidney injury in neonates with necrotizing enterocolitis: Risk factors and outcomes. Pediatric Res. 2021. https://doi.org/10.1038/s41390-020-01320-6 .
Criss, C. N. et al. Acute kidney injury in necrotizing enterocolitis predicts mortality. Pediatr. Nephrol. (Berl., Ger.). 33, 503–510 (2018).
doi: 10.1007/s00467-017-3809-y
Garg P. M. et al. Gestational age-specific clinical correlates of acute kidney injury in preterm infants with necrotizing enterocolitis. Pediatric Res. https://doi.org/10.1038/s41390-023-02736- 6. (2023).
Westreich, D. & Greenland, S. The Table 2 fallacy: Presenting and interpreting confounder and modifier coefficients. Am. J. Epidemiol. 177, 292–298 (2013).
doi: 10.1093/aje/kws412 pmcid: 3626058 pubmed: 23371353
Iacobelli, S. & Guignard, J. P. Maturation of glomerular filtration rate in neonates and infants: an overview. Pediatr. Nephrol. (Berl., Ger.). 36, 1439–1446 (2021).
doi: 10.1007/s00467-020-04632-1

Auteurs

Keia Sanderson (K)

University of North Carolina Department of Medicine-Nephrology, Chapel Hill, NC, USA. keia_sanderson@med.unc.edu.

Russell Griffin (R)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Nekayla Anderson (N)

Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.

Andrew M South (AM)

Department of Pediatrics, Section of Nephrology, Brenner Children's, Wake Forest University School of Medicine, Winston Salem, NC, USA.

Jonathan R Swanson (JR)

Division of Neonatology, Department of Pediatrics, University of Virginia School of Medicine, Charlottesville, VA, USA.

Michael Zappitelli (M)

Department of Pediatrics, Division of Nephrology, Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Montreal Children's Hospital, McGill University Health Centre, Montreal, QC, Canada.

Heidi J Steflik (HJ)

Division of Neonatal-Perinatal Medicine, Department of Pediatrics, Medical University of South Carolina, Charleston, SC, USA.

Marissa J DeFreitas (MJ)

Division of Pediatric Nephrology, Department of Pediatrics, University of Miami, Miami, FL, USA.

Jennifer Charlton (J)

University of Virginia, Department of Pediatrics, Division of Nephrology, Charlottesville, VA, USA.

David Askenazi (D)

Division of Nephrology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA.

Classifications MeSH